THE RISK OF OSTEONECROSIS OF THE JAW IN TAIWANESE OSTEOPOROTIC PATIENTS TREATED WITH ORAL ALENDRONATE OR RALOXIFENE

被引：0
|
作者：
Chiu, W. -Y. [1 ]
Chien, J. -Y. [2 ]
Yang, W. -S. [3 ]
Juang, J. -M J. [2 ]
Lee, J. -J. [4 ]
Tsai, K. -S. [1 ]
机构：
[1] Natl Taiwan Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Taipei 100, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan
[3] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan
[4] Natl Taiwan Univ Hosp, Dept Dent, Div Oral & Maxillofacial Surg, Taipei, Taiwan
来源：
OSTEOPOROSIS INTERNATIONAL | 2014年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P695
引用
收藏
页码：S430 / S431
页数：2
相关论文
共 50 条
  • [31] Risk comparison of osteonecrosis of the jaw in osteoporotic patients treated with bisphosphonates vs. denosumab: a multi-institutional retrospective cohort study in Taiwan
    Liu, Fang-Chun
    Luk, Kwing-Chi
    Chen, Yung-Chih
    OSTEOPOROSIS INTERNATIONAL, 2023, 34 (10) : 1729 - 1737
  • [32] Risk comparison of osteonecrosis of the jaw in osteoporotic patients treated with bisphosphonates vs. denosumab: a multi-institutional retrospective cohort study in Taiwan
    Fang-Chun Liu
    Kwing-Chi Luk
    Yung-Chih Chen
    Osteoporosis International, 2023, 34 : 1729 - 1737
  • [33] Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates
    King, Amber E.
    Umland, Elena M.
    PHARMACOTHERAPY, 2008, 28 (05): : 667 - 677
  • [34] Prevalence of Osteonecrosis of the Jaw in Patients With Oral Bisphosphonate Exposure
    Lo, Joan C.
    O'Ryan, Felice S.
    Gordon, Nancy P.
    Yang, Jingrong
    Hui, Rita L.
    Martin, Daniel
    Hutchinson, Matthew
    Lathon, Phenius V.
    Sanchez, Gabriela
    Silver, Paula
    Chandra, Malini
    McCloskey, Carolyn A.
    Staffa, Judy A.
    Willy, Mary
    Selby, Joe V.
    Go, Alan S.
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2010, 68 (02) : 243 - 253
  • [35] Jaw Osteonecrosis in Patients Treated with Bisphosphonates: An Ultrastructural Study
    Perrotta, I.
    Cristofaro, M. G.
    Amantea, M.
    Russo, E.
    De Fazio, S.
    Zuccala, V.
    Conforti, F.
    Amorosi, A.
    Donato, G.
    Tripepi, S.
    Giudice, M.
    ULTRASTRUCTURAL PATHOLOGY, 2010, 34 (04) : 207 - 213
  • [36] OSTEONECROSIS OF THE JAW IN PATIENTS WITH MULTIPLE MYELOMA TREATED WITH BISPHOSPHANATES
    Pavkovic, M.
    Petrushevska, G.
    Sotirova, T.
    Trpkovska-Terzieva, S.
    Karanfilski, O.
    Cevreska, L.
    Stankovic, S.
    Stojanovic, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 594 - 594
  • [37] OSTEONECROSIS OF THE JAW IN PATIENTS WITH OSTEOPOROSIS RECEIVING ORAL BISPHOSPHONATES
    Dalai, C.
    Ciavoi, G.
    Suciu, R.
    Cioara, F.
    Pascalau, N.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S443 - S443
  • [38] Oral risk factors associated with medication-related osteonecrosis of the jaw in patients with cancer
    Ueda, Nobuhiro
    Aoki, Kumiko
    Shimotsuji, Hiroko
    Nakashima, Chie
    Kawakami, Mao
    Imai, Yuichiro
    Kirita, Tadaaki
    JOURNAL OF BONE AND MINERAL METABOLISM, 2021, 39 (04) : 623 - 630
  • [39] Oral risk factors associated with medication-related osteonecrosis of the jaw in patients with cancer
    Nobuhiro Ueda
    Kumiko Aoki
    Hiroko Shimotsuji
    Chie Nakashima
    Mao Kawakami
    Yuichiro Imai
    Tadaaki Kirita
    Journal of Bone and Mineral Metabolism, 2021, 39 : 623 - 630
  • [40] Relationship between oral condition and risk factors for jaw osteonecrosis in patients with hip fractures
    Yamamoto, Norio
    Sukegawa, Shintaro
    Sukegawa-Takahashi, Yuka
    Honda, Toru
    Furuki, Yoshihiko
    Kawasaki, Keisuke
    Ozaki, Toshifumi
    JOURNAL OF MEDICAL INVESTIGATION, 2020, 67 (3-4): : 328 - 331
12345